Nbty Inc (NTY) Financial Statements (2026 and earlier)

Company Profile

Business Address 90 ORVILLE DR
BOHEMIA, NY 11716
State of Incorp. DE
Fiscal Year End September 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2015
Q1
9/30/2015
Q4
6/30/2015
Q3
3/31/2015
Q2
12/31/2014
Q1
9/30/2014
Q4
6/30/2014
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments303,350282,908250,398212,047139,48894,417
Cash and cash equivalent303,350282,908250,398212,047139,48894,417
Receivables198,693192,315208,451185,416175,701184,532
Inventory, net of allowances, customer advances and progress billings844,223809,050780,100803,386853,226872,766
Inventory844,223809,050780,100803,386853,226872,766
Other current assets59,83150,40148,80869,25978,82478,846
Deferred tax assets56,194     
Other undisclosed current assets  25,65126,60326,95528,91524,373
Total current assets:1,462,2911,360,3251,314,3601,297,0631,276,1541,254,934
Noncurrent Assets
Property, plant and equipment605,708608,027591,895593,793597,202590,365
Intangible assets, net (including goodwill)2,768,6282,875,5972,855,3882,912,8482,954,8743,215,959
Goodwill1,104,0901,132,5071,118,8671,146,4701,163,2821,274,447
Intangible assets, net (excluding goodwill)1,664,5381,743,0901,736,5211,766,3781,791,5921,941,512
Other noncurrent assets17,8529,51221,15747,14249,49264,521
Total noncurrent assets:3,392,1883,493,1363,468,4403,553,7833,601,5683,870,845
TOTAL ASSETS:4,854,4794,853,4614,782,8004,850,8464,877,7225,125,779
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities532,040535,458504,715463,067530,269455,512
Taxes payable     37,147 
Employee-related liabilities     44,189 
Accounts payable282,479293,935269,694265,732227,877256,615
Accrued liabilities249,561241,523235,021197,335221,056198,897
Debt34,496 174246261295
Other undisclosed current liabilities     (81,336) 
Total current liabilities:566,536535,458504,889463,313449,194455,807
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,129,1582,111,8072,107,7572,158,0022,158,0872,158,203
Long-term debt, excluding current maturities  2,111,8072,107,7572,158,0022,158,0872,158,203
Capital lease obligations 46,442     
Other undisclosed long-term debt and lease obligation2,082,716     
Liabilities, other than long-term debt702,298736,078728,991749,850761,348821,547
Deferred tax liabilities, net663,023691,809691,767705,472707,962747,900
Other liabilities39,27544,26937,22444,37853,38673,647
Total noncurrent liabilities:2,831,4562,847,8852,836,7482,907,8522,919,4352,979,750
Total liabilities:3,397,9923,383,3433,341,6373,371,1653,368,6293,435,557
Temporary equity, including noncontrolling interest      
Equity
Equity, attributable to parent1,456,4871,470,1181,441,1631,479,6811,509,0931,690,222
Additional paid in capital1,542,5841,563,0731,562,4271,561,7461,561,0141,560,298
Accumulated other comprehensive income (loss)(102,779)(76,519)(111,243)(58,788)(29,203)11,502
Retained earnings (accumulated deficit) 16,682(16,436)(10,021)(23,277)(22,718)118,422
Total equity:1,456,4871,470,1181,441,1631,479,6811,509,0931,690,222
TOTAL LIABILITIES AND EQUITY:4,854,4794,853,4614,782,8004,850,8464,877,7225,125,779

Income Statement (P&L) ($ in thousands)

12/31/2015
Q1
9/30/2015
Q4
6/30/2015
Q3
3/31/2015
Q2
12/31/2014
Q1
9/30/2014
Q4
6/30/2014
Q3
Revenues
(Revenue, Net)
796,867815,610787,876825,771813,548806,961
Cost of revenue(443,536)(476,387)(486,053)(486,968)(448,696)(480,640)
Cost of product and service sold(522,359)(430,538)(438,864)(450,549)(536,121)(431,204)
Gross profit:353,331339,223301,823338,803364,852326,321
Operating expenses(350,671)(261,332)(251,194)(243,278)(484,988)(247,033)
Other undisclosed operating loss     (20,862) 
Operating income (loss):2,66077,89150,62995,525(140,998)79,288
Nonoperating income (expense)(1,562)2,1272,525(1,355)(2,518)2,534
Gain (loss), foreign currency transaction, before tax(4,979)  87  
Interest and debt expense   (32,426)(34,747)(34,340)(33,794)
Other undisclosed loss from continuing operations before equity method investments, income taxes(33,165)(32,593)    
Income (loss) from continuing operations before income taxes:(32,067)47,42520,72859,423(177,856)48,028
Income tax expense (benefit)26,092(13,547)(7,472)(21,232)36,716(14,761)
Income (loss) from continuing operations:(5,975)33,87813,25638,191(141,140)33,267
Income (loss) before gain (loss) on sale of properties:(5,975)33,87813,25638,191(141,140)33,267
Net income (loss):(5,975)33,87813,25638,191(141,140)33,267
Net income attributable to noncontrolling interest      
Net income (loss) available to common stockholders, diluted:(5,975)33,87813,25638,191(141,140)33,267

Comprehensive Income ($ in thousands)

12/31/2015
Q1
9/30/2015
Q4
6/30/2015
Q3
3/31/2015
Q2
12/31/2014
Q1
9/30/2014
Q4
6/30/2014
Q3
Net income (loss):(5,975)33,87813,25638,191(141,140)33,267
Other comprehensive income (loss)2,852(1,975)1,69746  
Comprehensive income (loss):(3,123)31,90314,95338,237(141,140)33,267
Comprehensive income, net of tax, attributable to noncontrolling interest      
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (29,233)36,699(54,152)(29,631)(40,703)11,826
Comprehensive income (loss), net of tax, attributable to parent:(32,356)68,602(39,199)8,606(181,843)45,093

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: